Literature DB >> 29449263

Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?

Paul Kurdyak1, Binu Jacob2, Juveria Zaheer3, Benedikt Fischer4.   

Abstract

OBJECTIVE: To describe recent trends and patterns in methadone maintenance treatment (MMT) practice regionally and over time in the province of Ontario.
DESIGN: Population-based descriptive study using health administrative data between September 1, 2011, and December 31, 2014.
SETTING: Ontario. PARTICIPANTS: All active MMT-prescribing physicians and patients receiving MMT in the study period. MAIN OUTCOME MEASURES: Characteristics of MMT-prescribing physicians, including age, sex, specialty type, practice region, and practice volume; characteristics of patients receiving MMT, including age, sex, neighbourhood income, and region of residence.
RESULTS: Between September 1, 2011, and December 31, 2014, the number of MMT-prescribing physicians and patients who received MMT increased by 26% and 42%, respectively. In 2014, there was a total of 312 MMT-prescribing physicians and 49 703 patients receiving MMT. In 2014 and on a per capita basis, patients receiving MMT were more prevalent in rural regions; and within rural regions, there were disproportionately large numbers of young female MMT patients residing in low-income neighbourhoods.
CONCLUSION: The number of physicians prescribing MMT and patients receiving MMT has increased substantially between 2011 and 2014, with the largest per capita distribution occurring in rural regions and involving young adults. While availability of and access to MMT has improved considerably from before 2000 to levels of high use, these developments are likely influenced by recent trends in the proliferation of prescription opioid misuse across general populations. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29449263      PMCID: PMC5964406     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  37 in total

1.  Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time.

Authors:  B Fischer; J Rehm; T Blitz-Miller
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

2.  Characterizing the emerging population of prescription opioid abusers.

Authors:  Stacey C Sigmon
Journal:  Am J Addict       Date:  2006 May-Jun

3.  The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.

Authors:  Julie Bruneau; Elise Roy; Nelson Arruda; Geng Zang; Didier Jutras-Aswad
Journal:  Addiction       Date:  2012-03-22       Impact factor: 6.526

4.  The cost of providing methadone maintenance treatment in Ontario, Canada.

Authors:  Gregory S Zaric; Andrew W Brennan; Michael Varenbut; Jeff M Daiter
Journal:  Am J Drug Alcohol Abuse       Date:  2012-07-11       Impact factor: 3.829

Review 5.  Prescription opioid abuse, pain and addiction: clinical issues and implications.

Authors:  Walter Ling; Larissa Mooney; Maureen Hillhouse
Journal:  Drug Alcohol Rev       Date:  2011-05

6.  Effects of adding behavioral treatment to opioid detoxification with buprenorphine.

Authors:  W K Bickel; L Amass; S T Higgins; G J Badger; R A Esch
Journal:  J Consult Clin Psychol       Date:  1997-10

7.  Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure.

Authors:  Evan Wood; Mark W Tyndall; Patricia M Spittal; Kathy Li; Aslam H Anis; Robert S Hogg; Julio S G Montaner; Michael V O'Shaughnessy; Martin T Schechter
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

Review 8.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

9.  Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.

Authors:  Brent A Moore; David A Fiellin; Declan T Barry; Lynn E Sullivan; Marek C Chawarski; Patrick G O'Connor; Richard S Schottenfeld
Journal:  J Gen Intern Med       Date:  2007-04       Impact factor: 5.128

10.  The burden of premature opioid-related mortality.

Authors:  Tara Gomes; Muhammad M Mamdani; Irfan A Dhalla; Stephen Cornish; J Michael Paterson; David N Juurlink
Journal:  Addiction       Date:  2014-07-07       Impact factor: 6.526

View more
  4 in total

1.  Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model.

Authors:  Robert A Kleinman; Thomas D Brothers; Marlon Danilewitz; Anees Bahji
Journal:  J Addict Med       Date:  2022-01-11       Impact factor: 4.647

2.  Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in Northern Ontario, Canada.

Authors:  Cayley Russell; Maria Neufeld; Pamela Sabioni; Thepikaa Varatharajan; Farihah Ali; Sarah Miles; Joanna Henderson; Benedikt Fischer; Jürgen Rehm
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

3.  Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder.

Authors:  Paul J Joudrey; Marynia Kolak; Qinyun Lin; Susan Paykin; Vidal Anguiano; Emily A Wang
Journal:  JAMA Netw Open       Date:  2022-04-01

4.  Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada.

Authors:  Paul J Joudrey; Zoe M Adams; Paxton Bach; Sarah Van Buren; Jessica A Chaiton; Lucy Ehrenfeld; Mary Elizabeth Guerra; Brynna Gleeson; Simeon D Kimmel; Ashley Medley; Wassim Mekideche; Maxime Paquet; Minhee Sung; Melinda Wang; R O Olivier You Kheang; Jingxian Zhang; Emily A Wang; E Jennifer Edelman
Journal:  JAMA Netw Open       Date:  2021-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.